Skip to content

Trimethaphan camsylate

Arfonad (trimethaphan camsylate) is a small molecule pharmaceutical. Trimethaphan camsylate was first approved as Arfonad on 1982-01-01. It is used to treat aortic aneurysm, malignant hypertension, and pulmonary edema in the USA.
Trade Name Arfonad
Common Name Trimethaphan camsylate
Indication aortic aneurysm, malignant hypertension, pulmonary edema
Drug Class
Trimethaphan camsylate
Get full access now